<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03112564</url>
  </required_header>
  <id_info>
    <org_study_id>HUPH:PI:13/15</org_study_id>
    <nct_id>NCT03112564</nct_id>
  </id_info>
  <brief_title>Endotracheal Intubation Without Muscle Relaxants</brief_title>
  <official_title>Evaluation of the Effectiveness and Safety of Endotracheal Intubation for Inhalational Anesthesia Without the Use of Muscle Relaxants or Analgesics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Puerta de Hierro University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Puerta de Hierro University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective study conducted between March 2013 and November 2014 at Hospital Universitario
      Puerta de Hierro-Majadahonda, in Madrid, Spain to identify complications and evaluate the
      efficacy of pure inhalational anesthesia induction to achieve endotracheal intubation without
      the use of muscle relaxant and analgesic drugs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective study conducted between March 2013 and November 2014 at Hospital
      Universitario Puerta de Hierro-Majadahonda, in Madrid, Spain, with the previous approval by
      the institutional clinical research ethics committee. A total of 91 subjects who underwent
      general, gastrointestinal, orthopedic, urology and neurological surgery were randomly
      selected and provided written informed consent before any study-related procedures were
      performed.

      The aim of this study was to identify complications and evaluate the efficacy of pure
      inhalational anesthesia induction to achieve endotracheal intubation without the use of
      muscle relaxant and analgesic drugs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2013</start_date>
  <completion_date type="Actual">December 15, 2014</completion_date>
  <primary_completion_date type="Actual">November 30, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of treatment-emergent adverse events during intubation</measure>
    <time_frame>Time from anesthesia induction to 12 hours after the end of surgery</time_frame>
    <description>Measurement of time lapsed from the loss of blink reflex after anesthesia induction and endotracheal tube placement. Number of patients with difficulty for intubation and number of patients with mean arterial pressure variations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction following surgery</measure>
    <time_frame>from the end of surgery until the discharge day up to 7 days</time_frame>
    <description>subjects opinion regarding surgery satisfaction was collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative nausea and vomiting</measure>
    <time_frame>first 12 hours after surgery</time_frame>
    <description>record of nausea and/or vomiting events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">91</enrollment>
  <condition>Muscle Relaxation</condition>
  <condition>Intubation Complication</condition>
  <arm_group>
    <arm_group_label>Sevoflurane 8% + Intravenous fentanyl</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Avoidance of rocuronium/cisatracurium</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Avoidance of rocuronium/cisatracurium</intervention_name>
    <description>Anesthesia induction was performed at tidal volume, avoiding the use of analgesics and/or muscle relaxants with FGF of 6 L/min. Induction time was shortened as the FGF was increased. Once 5% sevoflurane end-tidal volume was reached, ventilation with facial mask was maintained for three more minutes. The time lapsed until the loss of blink reflex was achieved and orotracheal tube (OTT) was placed, difficulties in OTT placement, sevoflurane end-tidal volume after OTT placement, complications related to OTT insertion (movement, coughing, rigidity, apnea), mean arterial pressure (MAP) variations were measured. No muscle relaxants were given during surgery.</description>
    <arm_group_label>Sevoflurane 8% + Intravenous fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane 8% + Intravenous fentanyl</intervention_name>
    <description>Sevoflurane 8% + Intravenous fentanyl was the regimen used for induction and maintenance of anesthesia</description>
    <arm_group_label>Sevoflurane 8% + Intravenous fentanyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or Female patients

          -  Age ≥ 18 years

          -  ASA ≤ 3

          -  Able to provide informed consent

        Exclusion Criteria:

          -  Subjects with left ventricle ejection fraction (LEVF) ≤ 35%

          -  History of ischemic heart disease in the last year

          -  History of malignant hyperthermia

          -  Presence of thoracic drain tubes

          -  Increased intracranial pressure (ICP) or brain tumors, undergoing neurophysiological
             monitoring

          -  Hemodynamic instability or likely to become unstable during induction of anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Romero Berrocal, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Puerta de Hierro, Madrid, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Scheller MS, Zornow MH, Saidman LJ. Tracheal intubation without the use of muscle relaxants: a technique using propofol and varying doses of alfentanil. Anesth Analg. 1992 Nov;75(5):788-93.</citation>
    <PMID>1416135</PMID>
  </reference>
  <reference>
    <citation>Savarese JJ, Caldwell JE, Lien CA, Miller RD. Pharmacology of muscle relaxants and their antagonists. Anesthesia. 2000;5:412-90.</citation>
  </reference>
  <reference>
    <citation>Stevens JB, Wheatley L. Tracheal intubation in ambulatory surgery patients: using remifentanil and propofol without muscle relaxants. Anesth Analg. 1998 Jan;86(1):45-9.</citation>
    <PMID>9428849</PMID>
  </reference>
  <reference>
    <citation>Joo HS, Perks WJ. Sevoflurane versus propofol for anesthetic induction: a meta-analysis. Anesth Analg. 2000 Jul;91(1):213-9.</citation>
    <PMID>10866915</PMID>
  </reference>
  <reference>
    <citation>Trépanier CA, Brousseau C, Lacerte L. Myalgia in outpatient surgery: comparison of atracurium and succinylcholine. Can J Anaesth. 1988 May;35(3 ( Pt 1)):255-8.</citation>
    <PMID>3289770</PMID>
  </reference>
  <reference>
    <citation>Kirkbride DA, Parker JL, Williams GD, Buggy DJ. Induction of anesthesia in the elderly ambulatory patient: a double-blinded comparison of propofol and sevoflurane. Anesth Analg. 2001 Nov;93(5):1185-7, table of contents.</citation>
    <PMID>11682393</PMID>
  </reference>
  <reference>
    <citation>Thwaites A, Edmends S, Smith I. Inhalation induction with sevoflurane: a double-blind comparison with propofol. Br J Anaesth. 1997 Apr;78(4):356-61.</citation>
    <PMID>9135350</PMID>
  </reference>
  <reference>
    <citation>Knaggs CL, Drummond GB. Randomized comparison of three methods of induction of anaesthesia with sevoflurane. Br J Anaesth. 2005 Aug;95(2):178-82. Epub 2005 Apr 29.</citation>
    <PMID>15863438</PMID>
  </reference>
  <reference>
    <citation>Topuz D, Postaci A, Sacan O, Yildiz N, Dikmen B. A comparison of sevoflurane induction versus propofol induction for laryngeal mask airway insertion in elderly patients. Saudi Med J. 2010 Oct;31(10):1124-9.</citation>
    <PMID>20953528</PMID>
  </reference>
  <reference>
    <citation>Walpole R, Logan M. Effect of sevoflurane concentration on inhalation induction of anaesthesia in the elderly. Br J Anaesth. 1999 Jan;82(1):20-4.</citation>
    <PMID>10325830</PMID>
  </reference>
  <reference>
    <citation>Vidal MA, Calderón E, Martínez E, Pernia A, Torres LM. [Comparison of 2 techniques for inhaled anesthetic induction with sevoflurane in coronary artery revascularization]. Rev Esp Anestesiol Reanim. 2006 Dec;53(10):639-42. Spanish.</citation>
    <PMID>17302078</PMID>
  </reference>
  <reference>
    <citation>Siddik-Sayyid SM, Aouad MT, Taha SK, Daaboul DG, Deeb PG, Massouh FM, Muallem MR, Baraka AS. A comparison of sevoflurane-propofol versus sevoflurane or propofol for laryngeal mask airway insertion in adults. Anesth Analg. 2005 Apr;100(4):1204-9.</citation>
    <PMID>15781547</PMID>
  </reference>
  <reference>
    <citation>Bel Marcoval I, Gambús Cerrillo P. [Risk assessment, prophylaxis and treatment for postoperative nausea and vomiting]. Rev Esp Anestesiol Reanim. 2006 May;53(5):301-11. Review. Spanish.</citation>
    <PMID>16827070</PMID>
  </reference>
  <reference>
    <citation>Philip BK, Lombard LL, Roaf ER, Drager LR, Calalang I, Philip JH. Comparison of vital capacity induction with sevoflurane to intravenous induction with propofol for adult ambulatory anesthesia. Anesth Analg. 1999 Sep;89(3):623-7.</citation>
    <PMID>10475291</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>April 7, 2017</last_update_submitted>
  <last_update_submitted_qc>April 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Puerta de Hierro University Hospital</investigator_affiliation>
    <investigator_full_name>Antonio Romero Berrocal</investigator_full_name>
    <investigator_title>Anesthesiology and Critical Care</investigator_title>
  </responsible_party>
  <keyword>Endotracheal intubation</keyword>
  <keyword>muscle relaxants</keyword>
  <keyword>inhalational anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Hypotonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Cisatracurium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

